This is called gastric emptying delay
However, this may be a viable strategy for GLP-1 RA use in weight management. Jay Horowitz, APRN, CRNA, states, It is imperative to stay on top of new technologies and medication to ensure patient safety and provide optimal care. He has published articles in Outpatient Surgery Magazine sharing his experience as an anesthesia clinical leader working in two fast-paced, progressive, single-specialty (Ophthalmology) ASCs providing local with sedation anesthesia
Researchers seeking access to retatrutide for any clinical context, including individual treatment, should contact Eli Lilly directly or enrol in an authorized clinical trial
Many people regain weight after stopping GLP-1 medications, especially if the medication was doing most of the appetite regulation and long-term habits were not fully established
Although weight changes can occur during treatment, the Ozempic brand is approved for type 2 diabetes rather than chronic weight management